Calcification and cardiovascular problems in renal failure

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biochemistry

Background:

• Extraosseous calcification, particularly vascular calcification, is a significant complication in renal failure patients undergoing hemodialysis.
• Historically underestimated, its impact on mortality is now recognized, especially following the identification of hyperphosphatemia as a key predictor of all-cause and cardiac mortality.

Purpose of the Study:

• To review recent insights into the mechanisms and implications of extraosseous and vascular calcification in renal failure.
• To highlight the role of hyperphosphatemia in driving these calcifications and discuss evolving management strategies.

Main Methods:

• Review of recent scientific literature and clinical studies.
• Analysis of the impact of bone turnover and mineral metabolism on vascular calcification.
• Examination of the molecular pathways involved in hyperphosphatemia-induced calcification.

Main Results:

• Hyperphosphatemia is a strong predictor of mortality in renal failure patients.
• Both high and low bone turnover states contribute to vascular calcification risk.
• Vascular calcification exacerbates cardiac mortality through coronary atherosclerosis and arterial stiffness.
• Hyperphosphatemia-induced calcification involves active processes beyond passive mineral deposition.

Conclusions:

• Management of hyperphosphatemia is crucial for improving survival in renal failure.
• Understanding the active mechanisms of calcification and the role of inhibitors is vital for therapeutic development.
• Revised guidelines for hyperphosphatemia management are needed, despite implementation challenges.